Definitions
Sorry, no definitions found. You may find more data at nnrti.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word NNRTI.
Examples
-
(Agenerase) and the NNRTI nevirapine (Viramune) did not inhibit the growth of the malaria parasite.
-
We've also heard, as you mentioned before, Kyra, about resistance to some of the good drugs that are out there, for example, one of the best drugs called NNRTI.
-
Two of these studies were conducted in clinically advanced, three-class ARV non-nucleoside reverse transcriptase inhibitor (NNRTI), nucleoside reverse transcriptase inhibitor (NRTI), protease inhibitor (PI) treatment-experienced adults and one was conducted in treatment-naïve adults.
unknown title 2011
-
The ritonavir-boosted protease inhibitors studied were lopinavir, atazanavir, darunavir and fosamprenavir; the NNRTI was efavirenz and the NRTI was tenofovir.
unknown title 2011
-
The HIV medicines evaluated in these studies included ritonavir, ritonavir-boosted protease inhibitors, a non-nucleoside reverse-transcriptase inhibitor (NNRTI) and a nucleotide analogue reverse-transcriptase inhibitor (NRTI).
unknown title 2011
-
Two of these studies were conducted in clinically advanced, three-class ARV non-nucleoside reverse transcriptase inhibitor (NNRTI), nucleoside reverse transcriptase inhibitor (NRTI), protease inhibitor (PI) treatment-experienced adults and one was conducted in treatment-naïve adults.
unknown title 2011
-
"Intrapartum and neonatal single-dose nevirapine (NVP) reduces the risk of mother-to-child HIV transmission but also induces viral resistance to non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs," write the authors of a
-
"Intrapartum and neonatal single-dose nevirapine (NVP) reduces the risk of mother-to-child HIV transmission but also induces viral resistance to non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs," write the authors of a
-
RDEA806, for the treatment of HIV, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that has successfully completed a Phase 2a study in HIV patients.
-
Overall, 46 percent of patients were protease inhibitor (PI) - naive and 13 percent were non-nucleoside reverse transcriptase inhibitor (NNRTI) - naive; 86 percent were susceptible to eight PIs (excluding ritonavir) and 60 percent were susceptible to at least two NRTIs in their OBR.
THE MEDICAL NEWS Editors 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.